ProBio
ProBio is a global Contract Development and Manufacturing Organization (CDMO) enabling biotech and pharmaceutical companies to advance the development and manufacturing of next generation therapies. With deep expertise in cell and gene therapy, ProBio delivers integrated, end to end solutions across mRNA, plasmid DNA, viral vectors, and in vivo CAR T therapies.ProBio's scalable, GMP compliant platforms support partners from early development through commercial manufacturing, helping accelerate timelines and de risk complex programs. Through a collaborative, risk sharing model, ProBio also offers flexible options for licensing and co development, empowering partners to efficiently navigate the scientific and regulatory challenges of advanced therapeutics.Content by ProBio
| 6 min read
As soaring costs and logistical complexity strain traditional cell therapy models, in vivo CAR T is prompting a fundamental rethink of how advanced therapies are manufactured and scaled.
Page 1 of 1 - 1 Total Items
